| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/19/1995 | CA2165778A1 Growth differentiation factor-7 |
| 01/19/1995 | CA2165776A1 Growth differentiation factor-6 |
| 01/19/1995 | CA2165078A1 Erythromycin derivatives |
| 01/19/1995 | CA2164960A1 Novel (1-phenyl-1-heterocyclyl)methanol and (1-phenyl-1-heterocyclyl)methylamine derivatives |
| 01/19/1995 | CA2164876A1 Novel (1-phenyl-1-heterocyclyl) alkane derivatives and their use as neuroprotective agents |
| 01/19/1995 | CA2164856A1 Novel (1-heteroazolyl-1-heterocyclyl) alkane derivatives and their use as neuroprotective agents |
| 01/19/1995 | CA2164100A1 Pharmaceutical preparations for poorly-soluble active agents |
| 01/19/1995 | CA2163994A1 Piperidinyl substituted methanoanthracenes as d1/d2-antagonists and 5ht2-serotanin-antagonists |
| 01/19/1995 | CA2143437A1 Novel substance dc114-a1 |
| 01/18/1995 | EP0634436A1 Sulfate of n-acetylneuraminic acid homopolymer, process for producing the same, anti-hiv drug containing said sulfate, method of treating aids with said sulfate, use of said sulfate for treating aids, and use of said sulfate for producing the drug |
| 01/18/1995 | EP0634414A1 Isolation and structure of spongistatins 5,7,8,and 9 and their use as antitumor agents |
| 01/18/1995 | EP0634411A1 Process for the preparation of 8-(4'C4"-(pyrimidin-2'''-yl)-piperazin-1''-yl)-butyl)-8-aza-spiro(4,5)decan-7,9-dione and of its hydrochlorides of high purity |
| 01/18/1995 | EP0634410A1 Process for the preparation of a N-tert.butylisoquinolin-3-carboxamide derivative and intermediate compounds of these process |
| 01/18/1995 | EP0634401A1 MDR reversal agents |
| 01/18/1995 | EP0634400A1 Pyridinecarboximidamide compound and use thereof |
| 01/18/1995 | EP0634398A1 4-Phenylpiperidinyl-1/-piperazinyl-1-ethylsubstituted benzofusedheterocycles as antiarrhythmic agents |
| 01/18/1995 | EP0634396A1 Amino acid derivatives and their use as inhibitors of encephalinase |
| 01/18/1995 | EP0634392A2 Esters of acyl L-carnitines and pharmaceutical compositions containing same for treating endotoxic shock |
| 01/18/1995 | EP0634175A1 Pharmaceutical combination, containing a renin-angiotensin-system inhibitor and an endothelin antagonist |
| 01/18/1995 | EP0634174A1 Antianemic composition for veterinary use |
| 01/18/1995 | EP0634173A1 24-epi-1-alpha-hydroxyvitamin D2 for treating osteoporosis |
| 01/18/1995 | EP0634172A1 Dermatologic preparation composition containing prostacyclin as active ingredient |
| 01/18/1995 | EP0634171A1 Pharmaceutical composition for treating cerebral thrombosis |
| 01/18/1995 | EP0634170A1 Compositions containing 8-hydroxy-quinoline for use in the treatment of hyperproliferative skin diseases |
| 01/18/1995 | EP0634169A1 Pharmaceutical composition containing quinoline or quinazoline derivatives |
| 01/18/1995 | EP0634168A1 Nutritive composition |
| 01/18/1995 | EP0634013A1 A nicotine and/or nicotine metabolite detection system. |
| 01/18/1995 | EP0633943A1 Gene therapy using targeted viral vectors |
| 01/18/1995 | EP0633893A1 17-substituted steroids useful in cancer treatment |
| 01/18/1995 | EP0633887A1 Calanolide antiviral compounds, compositions and uses thereof |
| 01/18/1995 | EP0633886A1 Pharmaceutically active bicyclic-heterocyclic amines |
| 01/18/1995 | EP0633885A1 Triazoloquinoxalin-1,4-diones and their preparation and use |
| 01/18/1995 | EP0633884A1 (furan-2-yl)-2-(1-normon-2-yl) oxazole derivatives with antibacterial activity |
| 01/18/1995 | EP0633883A1 Process for the preparation of 4-pyridyl- and 4-piperidinylimidazoles useful as intermediates for the synthesis of histamine receptor antagonists |
| 01/18/1995 | EP0633882A1 4- 4'-piperidinyl or 3'-pirrolidinyl] substituted imidazoles as h3-receptor antagonists and therapeutic uses thereof |
| 01/18/1995 | EP0633881A1 Amine derivatives of oxo- and hydroxy-substitued hydrocarbons |
| 01/18/1995 | EP0633879A1 Enantiomeric 1-phenyl-2-(2-pyridinyl)ethylamine for the treatment of neurodegenerative disorders |
| 01/18/1995 | EP0633795A1 Antibacterial coated medical implants |
| 01/18/1995 | EP0633787A1 Pharmaceutical composition |
| 01/18/1995 | EP0633783A1 Rapamycin formulation for iv injection |
| 01/18/1995 | EP0633782A1 Pharmaceutical compositions containing monosialoganglioside derivatives suitable for the treatment of spinal cord injury |
| 01/18/1995 | EP0633781A1 Compositions and methods for treating benign prostatic hypertrophy |
| 01/18/1995 | EP0633779A1 USE OF $g(b)-CARBOLINES |
| 01/18/1995 | EP0633778A1 Medicament for the treatment of airways inflammation and airways hyperresponsiveness |
| 01/18/1995 | EP0633777A1 Parenteral solutions containing 3-dialkylaminoethoxybenzoyl-benzofurans |
| 01/18/1995 | EP0633776A1 Compounds useful for treating allergic and inflammatory diseases |
| 01/18/1995 | EP0633775A1 Compounds useful for treating inflammatory diseases and for inhibiting production of tumor necrosis factor |
| 01/18/1995 | EP0633774A1 Topical administration of toremifene and its metabolites |
| 01/18/1995 | EP0633773A1 Method of treatment of hyperpigmentation in black skin with retinoic acid and method of lightening black skin with retinoic acid |
| 01/18/1995 | EP0633772A1 Medicament against cardiac circulatory diseases |
| 01/18/1995 | EP0633770A1 Capsule filled with a mixture of active ingredient in powder form and highly dispersed silicon dioxide |
| 01/18/1995 | EP0633721A1 Decontaminating blood components with 8-methoxypsoralen |
| 01/18/1995 | EP0625045A4 Methods of treating inflammatory dermatoses. |
| 01/18/1995 | EP0621787A4 Skin therapeutic mixture containing cold-processed aloe vera extract, with yellow sap and aloin removed. |
| 01/18/1995 | EP0563112B1 Enhanced bioavailability pharmaceutical composition containing probucol |
| 01/18/1995 | EP0549686A4 Modified internucleoside linkages |
| 01/18/1995 | EP0466768B1 Short-chain triglycerides |
| 01/18/1995 | EP0284621B1 New psychostimulant agent |
| 01/18/1995 | CN1097425A 5-thia-1,4-diazabicyclo/4.2.0/octane-3,8-dioxo analogs of beta-lactam, process for the preparation thereof and the use thereof |
| 01/18/1995 | CN1097423A Quinolone- and naphthyridonecarboxylic acid derivatives |
| 01/18/1995 | CN1097422A 3N-alkyl-3,4-dihydro-2H-4-substituted heteroaromatic azyl-7,8,9,10(7,10)-naphthane-(2,1-e)-(1,3) |
| 01/18/1995 | CN1097421A Adhesion receptor antagonists |
| 01/18/1995 | CN1097420A Sulfonate and carbamate derivatives of 3-aroylbenzo|B¨thiophenes |
| 01/18/1995 | CN1097419A New preparation process for sulphurated derivatives of imidazole and the new intermediates obtained |
| 01/18/1995 | CN1097418A Preparation and application of 8-chloroquinolone carboxylic acid derivative |
| 01/18/1995 | CN1097417A 新的杂环化合物 New heterocyclic compounds |
| 01/18/1995 | CN1097415A N-substituted 2-hetero cyclicbutanol |
| 01/18/1995 | CN1097306A Compound anti-inflammation suppository |
| 01/18/1995 | CN1097305A A medicine kehongsu for silkworm to prevent disease and its manufacture |
| 01/18/1995 | CN1097304A Metronidazoli hydrochloride intramuscular injection |
| 01/18/1995 | CN1097303A Propylphenon skin penetrating composition |
| 01/17/1995 | US5382675 Polycyclic compounds and processes for the preparation thereof |
| 01/17/1995 | US5382670 Platelet activating factor antagonists |
| 01/17/1995 | US5382669 Process for the preparation of ergoline derivatives |
| 01/17/1995 | US5382663 Process for the preparation of diltiazem |
| 01/17/1995 | US5382601 Memantine-containing solid pharmaceutical dosage forms having an extended two-stage release profile and production thereof |
| 01/17/1995 | US5382598 Therapeutic amides |
| 01/17/1995 | US5382597 Organo-tin compounds having anti-tumour activity and anti-tumour compositions |
| 01/17/1995 | US5382596 Substituted 2-aminotetralins |
| 01/17/1995 | US5382594 Cognition activators |
| 01/17/1995 | US5382593 Antioxidants or anticoagulants |
| 01/17/1995 | US5382592 Antimigraine cyclobutenedione derivatives of tryptamines |
| 01/17/1995 | US5382591 Antipyretic and analgesic methods using optically pure R-ketorolac |
| 01/17/1995 | US5382588 Methyl piperidine derivatives of cinnamic acids, benzoic acids, benzoazols and benzophenones useful as skin anti-aging compounds |
| 01/17/1995 | US5382586 Tranquilizers |
| 01/17/1995 | US5382585 Treatment of cardiovascular disorders and erectile dysfunctions |
| 01/17/1995 | US5382584 Adenosine re-uptake inhibiting derivatives of diphenyl oxazoles, thiazoles and imidazoles |
| 01/17/1995 | US5382582 Methotrexate analogs and methods of using same |
| 01/17/1995 | US5382581 Anticarcinogenic agents or antitumor agents |
| 01/17/1995 | US5382578 Methods for treating convulsions and ischemia with substituted dibenzoxazepine compounds |
| 01/17/1995 | US5382577 Pharmaceutical composition for inhibiting platelet aggregation |
| 01/17/1995 | US5382576 4-phenyl morpholine |
| 01/17/1995 | US5382574 Diabetes |
| 01/17/1995 | US5382573 Hormone replacement therapy |
| 01/17/1995 | US5382572 Viricides |
| 01/17/1995 | US5382571 Clathrates of peroxyacids, their preparation and their uses |
| 01/17/1995 | US5382436 Caffeine in the treatment of Herpes simplex virus infections |
| 01/17/1995 | US5382434 Low steroid dose dry pharmaceutical preparation |
| 01/17/1995 | US5382432 Cosmetic method for treatment of skin |
| 01/17/1995 | US5382430 Osteogenesis, oviposition, shell strength improvement |